Indiana Clinical and Translational Sciences Institute: A statewide Laboratory for accelerating Clinical and Translational Research Anantha Shekhar MD,

Slides:



Advertisements
Similar presentations
National Center for Research Resources NATIONAL INSTITUTES OF HEALTH T r a n s l a t i n g r e s e a r c h f r o m b a s i c d i s c o v e r y t o i m.
Advertisements

Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
Stephen Klasko, MD, MBA Senior Vice President for USF Health Dean, College of Medicine 19 August 2010.
“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.
Better Outcomes. Delivered. Organization Overview January 2013 Copyright © 2013 Indiana Health Information Exchange, Inc.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Anantha Shekhar MD, PhD Indiana University School of Medicine Indiana Clinical and.
NCI Designation: Expanding Science and Promoting Health in the Region Name Title, Company Date.
STEM Education Reorganization April 3, STEM Reorganization: Background  The President has placed a very high priority on using government resources.
Kim Milford and Alan Walsh Engagement and Partnerships: Identity Outreach at Indiana University.
Brian C. Springer, MHA Executive Director Siteman Cancer Center Barnes-Jewish Hospital & Washington U. School of Med CCSG-CTSA Interactions Michael Bertram,
Bindley Bioscience Center Vision: Nurture interactive communication and interdisciplinary discovery with flexible laboratory project spaces and an open.
Oakland University William Beaumont School of Medicine.
Oakland University William Beaumont School of Medicine An Opportunity of a Lifetime.
Harvard Catalyst: How Can It Help Your Research? Steven D. Freedman MD PhD Professor of Medicine, HMS Associate Dean for Clinical and Translational Research,
1 Accelerating Research to Improve Health How the CCTS can Accelerate Your Research & Advance Your Career.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
The NIH Roadmap for Medical Research
Technology Transfer Funding Initiatives Linda D. Saffer, Ph.D. Technology Analysis Specialist.
INNOVATE INDIANA: Economic Development at IU Bill Stephan Vice President for Engagement, Indiana University Tony Armstrong President & CEO Indiana University.
UAMS CENTER FOR CLINICAL & TRANSLATIONAL RESEARCH (CCTR) CCTR Novel Methodologies UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES uams.edu/cctr Curtis L. Lowery,
Sustainable Smart Cities Symposium April 3, 2013 Richard B. Marchase Vice President for Research and Economic Development.
HUBZERO AT INDIANA UNIVERSITY: THE INDIANA CTSI HUB Bill Barnett EDUCAUSE October 14, 2010.
Working across sectors Building collaborative eco-systems Lars Sundstrom SARTRE.
Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics.
A Paradigm for Interdisciplinary Research A. H. Rebar, DVM, Ph.D. Senior Associate Vice President for Research Executive Director of Discovery Park.
TYPE 2 TRANSLATIONAL RESEARCH 2009 GRANT PROGRAMS UW Institute for Clinical and Translational Research (ICTR) Community-Academic Partnership Core (CAP)
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
First Annual Meeting. David Johnson, President and CEO BioCrossroads Indiana CTSI Annual Meeting January 7-8, 2009 BioCrossroads.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Overview: FY12 Strategic Communications Plan Meredith Fisher Director, Administration and Communication.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana CTSI 101 Indiana Clinical and Translational Sciences Institute Monday, October.
University of Louisville Faculty Discussion on Research Ho! Ho! Ho! Happy Holidays! 1 December 10,2009.
Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute Daniel F. Evans,
Indiana Institute For Personalized Medicine David A Flockhart MD, PhD Professor of Medicine, Genetics and Pharmacology Indiana University.
Department of Health and Human Services National Institutes of Health National Center for Research Resources Division of Research Infrastructure Extending.
IndianaCTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH The Indiana CTSI HUB Bill Barnett Director, Information Infrastructures, Indiana CTSI
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
Investing in the State of Innovation International Seminar on Knowledge and Innovation 1 October, 2013 Creating a High-Performance Innovation Ecosystem:
Chapter 6 – Data Handling and EPR. Electronic Health Record Systems: Government Initiatives and Public/Private Partnerships EHR is systematic collection.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
Project Funding & New Projects Cancer Care Engineering.
West Virginia Clinical Translational Science Institute Links Scientists and Teachers Sara Hanks, Ann Chester, Summer Kuhn.
A PDT is a committee of multidisciplinary researchers who assist investigators in developing ideas/hypotheses into well-designed translational projects.
6/4/20161 Commitment & Efforts Toward Translational Science Subtitle Placeholder.
Susan R. Kayar, PhD Health Scientist Administrator Research Infrastructure NCRR, NIH Funding Opportunities through the National Center for Research Resources.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH CTSI Funding Opportunities
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana CTSI 2014 Purdue Retreat Engagement with IU Health Arnett Marietta L. Harrison,
National Center for Research Resources G. Iris Obrams, M.D., M.P.H., Ph.D. NCRR Update 5 August 2006.
National Center for Research Resources NATIONAL INSTITUTES OF HEALTH T r a n s l a t I n g r e s e a r c h f r o m b a s i c d i s c o v e r y t o i m.
The Wisconsin Network for Health Research (WiNHR): Overview. An Infrastructure for Conducting Multi-Site Clinical Research across the State of Wisconsin.
The Importance of a Strategic Plan to Eliminate Health Disparities 2008 eHealth Conference June 9, 2008 Yvonne T. Maddox, PhD Deputy Director Eunice Kennedy.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
First Annual Meeting. Project Development Teams: Concept and Example Scott C. Denne, M.D. Professor of Pediatrics Associate Director of the Indiana CTSI.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Scott C. Denne, MD Associate Director, Indiana CTSI April 25, 2011 Plenary Session.
Foundation Doctors’ Academic Meeting Kathryn Adcock Wellcome Trust March 2011.
LEADING THE CREATION AND ADVANCEMENT OF HEALTH EQUITY SPRING BOARD OF TRUSTEES MEETING We are on a mission. Leveraging the State’s $35M Investment in MSM.
Clinical and Translational Science Awards (CTSAs) Future Directions and Opportunities for ACNP investigators.
Translational Research: Case of Istanbul University
Gestora brasileiro focada exclusivamente na área da saúde.
Opportunities to Pursue a Clinical and Translational Career at Penn Emma A. Meagher, MD Vice Dean for Clinical Research & Chief Clinical Research Officer.
Department of Medicine Michael Farkouh, Vice-Chair Research michael
ACTSI Presentation to MSCR Coloquium
What is CICATS? The University of Connecticut, in partnership with regional hospitals, state agencies, and community health care organizations, has.
Tamar Raz, PHD.
Clinical and Translational Science Awards Program
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Presentation transcript:

Indiana Clinical and Translational Sciences Institute: A statewide Laboratory for accelerating Clinical and Translational Research Anantha Shekhar MD, PhD Indiana CTSI

Bridging the Gap Source: Butler D. Translational research: Crossing the valley of death. Nature. 2008;453:840–2.

National Institutes of Health Clinical And Translational Science Awards In 2006, National Institutes of Health (NIH) developed the Clinical and Translational Science Award program (CTSA) led by the National Center for Research Resources (NCRR) CTSA works together as a national consortium of 55 institutions sharing a common vision to improve human health by transforming the research and training environment to enhance the efficiency and quality of clinical and translational research – helping scientists bridge laboratory discoveries to patient treatments When fully implemented by 2011, 60 institutions will be linked together to transform the local, regional, and national environment to increase the efficiency and speed of clinical and translational research across the country.   This slide is historical perspective does it need a title?

Access to National Consortium of Academic Health Centers – 55 to date

Indiana CTSI Partners – Providing Leveraging Opportunities Throughout the State Biocrossroads Clarian Health Partners Eli Lilly and Company Richard M. Fairbanks Foundation Indiana University Notre Dame Purdue University Cook Group, Inc Wellpoint, Inc. Atlanta CTSI An inter-institutional partnership between Emory University, Morehouse School of Medicine, Children’s Healthcare of Atlanta, and Georgia Tech. The ACTSI focus is on community engagement, training C&T investigators, and reducing health disparities. The goal is to extend the CTSA philosophy of interdisciplinary interactions and connectivity to generate partnerships and collaboration beyond the consortium to organizations involved with health care throughout the nation. It is through multiple partnerships that CTSAs will transform clinical and translational research and bring new scientific advances to health care. Roudebush VA Medical Center Regenstrief Institute Wishard Health Services Indiana State Government

Indiana CTSI Today A strong Indiana public-private partnership that extends beyond basic research and looks at specific programs to improve the health of Hoosiers and all Americans. State-wide laboratory created to transform health sciences research and health care delivery. Part of a National Consortium of 55 Academic Health Partners working together to accelerate biomedical discoveries across 28 states and DC. This slide is “who we are”

Goals Improve Health of Indiana & Beyond by: Creating Translational Research Acceleration Programs Training a New Cadre of Translational researchers Fostering Robust Community Engagement Streamlining Clinical Research Resources Leveraging Resources of the Greater Indiana Community

Goal 1. Translational Research Acceleration Programs Challenge: Scientists are on multiple campuses spread across the state Gap in communication between basic scientists making new discoveries and clinicians testing therapies in practice CTSI Solution: Pilot Grants Intercampus pilots are given to collaborative projects across 3 institutions on 5 campuses IU Bloomington, IUPUI, IU School of Medicine, PU, ND 134 applications received to date Awarded 22 to date Criteria – 2 campus connection. Program must be a new collaboration or new twist to existing collaboration and must generate additional funds.

Goal 1. Translational Research Acceleration Programs Challenge: Need novel mechanism to engage multiple faculty, non-biomedical investigators, young researchers, and industry partners CTSI Solution: Project development teams (PDT) multidisciplinary clinical research team comprised of Pharmacologists, Medicinal Chemists, Study Coordinators, Public/Industry, Statistician, Clinician, Tech Transfer, Regulatory Affairs and a Principal Investigator 8 PDTs established to date 8+ faculty/experts @ 1 FTE salary Each authorized up to $100K pilot funds 2 additional PDTs established with ARRA funds

Current Portfolio of PDT Projects Guideline Development Meta-analyses Systematic Reviews Dissemination & Implementation Research Health Systems Redesign Applied Health IT PRACTICE BENCH BEDSIDE Clinical Practice Delivery of Care Identification of New Clinical Questions and Gaps in Care Basic Science Research Preclinical Studies Animal Research Case Series Phase 1 and 2 Clinical Trials Human Clinical Research Controlled Observational Studies Phase 3 Clinical Trials Proof of Model Drug Concept Dev Dev Bench to Bedside Adult Medicine Pediatric Need to color code IU, PU, ND programs update slide Community Trans. Research Imaging Purdue Notre Dame

Goal 1. Translational Research Acceleration Programs Challenge: People find $, yet still struggle to get to the next critical step in discovery Pre angel investment Early stage funding Feasibility funds CTSI Solution: Bridging the gap in taking discovery to IP RISC Grants advance IP development RISC (Research for Invention and Scientific Commercialization) are IP boost grants up to $25K each First grant resulted in treatment patent that one pharma group is interested in pursuing Connect to Venture Capital of Licensing When ready for commercialization, provide link thru IUETC and Clarian Ventures

Goal 2. Training Translational Researchers Challenge: Need to improve the infrastructure and workforce CTSI Solution: Clinical Faculty Career Development Awards (17 awarded) Basic Research Faculty career development awards (5 new positions) Graduate Training (30 awarded) NIH K30 grant provides MS in Clinical research for MD, Nurses, Clinicians Translational science for engineering, PhDs MS in Translational Sciences Program for Research coordinator certification Undergraduate Research Fellowships (12 slots/year) K-12; High school student program (50 students) Project SEED Genetics Based Science Teachers

Goal 3. Robust Community Engagement Challenge: Improve clinical research availability through health literacy throughout the community and biobank CTSI Solution: Community Health Enhancement Program (CHEP) Over 170 active Community Partners engaged YMCA diabetes management program Advancing Community Engagement in Science (ACES) led by CTSI -10 other national CTSAs to develop best practices to do community based research Community Advisory Council established Focus areas meet monthly, entire group annually A New mechanism developed to supplement subject recruitment similar To PDTs CTSI SUCCESS: Indiana CTSI built a set of ‘tools’ for a national model for community engagement

Goal 4. Streamlining and Enhancing Clinical Research Resources Challenge: Need to engage more patients in clinical studies Regulatory barriers need to be shortened through contracts, IRBs Streamline the process so research moves through the continuum quickly Need more bricks and mortar infrastructure to do it correctly Need a place to conduct studies faster, better

More than 1 million admissions & outpatient visits Statewide Impact of IU Health - 2011 More than 20 hospitals, health centers, partners, affiliates & joint venture operations More than 19,000 employees More than 1 million admissions & outpatient visits ~ 4,200 patients participating in ~ 2,600 clinical trials ~ 60% of Indiana doctors trained at IUSM, thus have spent time in Clarian facilities.

Hospital Reach Participation includes: 68 hospitals (27 health systems) 5 payors Long-term care facilities Immediate Care centers Free-standing labs and imaging centers State and local public health agencies Copyright 2010 Indiana Health Information Exchange, Inc.

Patients Over 12 million unique patients Almost 4 billion structured results Ratio of patients in INPC to population (2007 census)

3 2 4 1 5

Clinical Research Support Office

Regulatory Processes

Subject Recruitment Office

Clinical Research Resources

Bio-banking Program

Goal 5. Leverage Community Resources Academic-Industry Partnerships – Indiana is rich in academic, health and life science resources Challenge: academic and industry working in a vacuum. Industry needs cutting edge research to commercialize and academia needs to know how to take a discovery to patients Indiana CTSI Solution: a perfect division of labor and strategic partnerships IU Bloomington, IU Med Center, Purdue, Notre Dame, IUPUI, University of Minnesota BioCrossroads, Clarian Health, Cook, Eli Lilly and Company, Richard M. Fairbanks Foundation, WellPoint, Inc., Roudebush VA Medical Center, Regenstrief Institute, Wishard Health Services, Indiana State Government 55 National CTSA consortium partner locations, 28 states and D.C.

Goal 5. Leverage Community Resources Other Significant Results to date: Disease Modeling and Personalized Medicine Program with Eli Lilly and Company Preventive and Individualized Medicine Technology Center (PRIME TEC) with CDI/Sony DADC FDA compliant Phase I Oncology unit with commercial partner Developing “i2i” with Cook Health Economics Program with WellPoint Indiana Health Study - Fairbanks Institute for Healthy Communities conducting a longitudinal study of the Indianapolis population